T1	Condition 86 101	Graves' disease
T2	Condition-Name 86 101	Graves' disease
E1	Condition:T1 Name:T2
T3	Condition 107 122	hyperthyroidism
T4	Condition-Name 107 122	hyperthyroidism
E3	Condition:T3 Name:T4
T5	Life-Stage-And-Gender 33 39	female
A1	Life-Stage-And-Gender-Type T5 female
T6	Life-Stage-And-Gender 25 29	Male
A2	Life-Stage-And-Gender-Type T6 male
T7	Observation 201 204	CAS
T8	Observation-Name 201 204	CAS
E7	Observation:T7 Name:T8 Eq-Comparison:E24 Severity:T80
T9	Observation 595 604	proptosis
T10	Observation-Name 595 604	proptosis
E9	Observation:T9 Name:T10 Eq-Comparison:E27
T13	Condition 1021 1037	immunomodulation
T14	Condition-Name 1021 1037	immunomodulation
E13	Condition:T13 Name:T14
T15	Condition 1254 1270	optic neuropathy
T16	Condition-Name 1254 1270	optic neuropathy
E15	Condition:T15 Name:T16
T17	Condition 1393 1404	optic nerve
T18	Condition-Name 1393 1404	optic nerve
E17	Condition:T17 Name:T18 Temporality:E81
T21	Procedure 1470 1489	orbital irradiation
T22	Procedure-Name 1470 1489	orbital irradiation
E21	Procedure:T21 Name:T22 Temporality:E84
T23	Eq-Operator 40 41	≥
A3	Eq-Operator-Value T23 GTEQ
T24	Eq-Operator 206 207	≥
A4	Eq-Operator-Value T24 GTEQ
T25	Eq-Operator 341 347	within
A5	Eq-Operator-Value T25 LTEQ
T26	Eq-Operator 543 544	≥
A6	Eq-Operator-Value T26 GTEQ
T27	Eq-Operator 605 606	≥
A7	Eq-Operator-Value T27 GTEQ
T28	Eq-Operator 867 868	≥
A8	Eq-Operator-Value T28 GTEQ
T29	Eq-Operator 919 925	within
A9	Eq-Operator-Value T29 LTEQ
T30	Eq-Operator 1038 1053	within the past
A10	Eq-Operator-Value T30 LTEQ
T31	Eq-Operator 1103 1104	<
A11	Eq-Operator-Value T31 LT
T32	Eq-Operator 1155 1156	<
A12	Eq-Operator-Value T32 LT
T33	Eq-Operator 1417 1423	within
A13	Eq-Operator-Value T33 LTEQ
T34	Eq-Temporal-Unit 45 50	years
A14	Eq-Temporal-Unit-Value T34 year
T35	Eq-Temporal-Unit 350 356	months
A15	Eq-Temporal-Unit-Value T35 month
T36	Eq-Temporal-Unit 928 933	weeks
A16	Eq-Temporal-Unit-Value T36 week
T37	Eq-Temporal-Unit 1056 1062	months
A17	Eq-Temporal-Unit-Value T37 month
T38	Eq-Temporal-Unit 1435 1441	months
A18	Eq-Temporal-Unit-Value T38 month
T39	Eq-Unit 547 549	mm
T40	Eq-Unit 609 611	mm
T41	Eq-Unit 1167 1170	mm3
T42	Age 54 57	age
E22	Age:T42 Eq-Comparison:E23
T43	Eq-Value 42 44	18
T44	Eq-Value 208 209	4
T47	Eq-Value 348 349	9
T48	Eq-Value 545 546	2
T49	Eq-Value 607 608	3
T50	Eq-Value 869 870	1
T51	Eq-Value 926 927	3
T52	Eq-Value 1054 1055	9
T53	Eq-Value 1105 1106	6
T54	Eq-Value 1156 1160	1500
T56	Eq-Value 1433 1434	6
T57	Eq-Comparison 40 50	≥ 18 years
E23	Eq-Comparison:T57 Operator:T23 Temporal-Unit:T34 Value:T43
T58	Eq-Comparison 206 209	≥ 4
E24	Eq-Comparison:T58 Operator:T24 Value:T44
T59	Eq-Comparison 341 356	within 9 months
E25	Eq-Comparison:T59 Operator:T25 Temporal-Unit:T35 Value:T47
T60	Eq-Comparison 543 549	≥ 2 mm
E26	Eq-Comparison:T60 Operator:T26 Unit:T39 Value:T48
T61	Eq-Comparison 605 624	≥ 3 mm above normal
E27	Eq-Comparison:T61 Operator:T27 Unit:T40 Value:T49 Unit2:T110 Operator2:T177
T62	Eq-Comparison 867 872	≥ 1 g
E28	Eq-Comparison:T62 Operator:T28 Value:T50 Unit:T123
T63	Eq-Comparison 919 933	within 3 weeks
E29	Eq-Comparison:T63 Operator:T29 Temporal-Unit:T36 Value:T51
T64	Eq-Comparison 1038 1062	within the past 9 months
E30	Eq-Comparison:T64 Operator:T30 Temporal-Unit:T37 Value:T52
T65	Eq-Comparison 1103 1109	< 6g/L
E31	Eq-Comparison:T65 Operator:T31 Value:T53 Unit:T141 Per:T142
T66	Eq-Comparison 1155 1170	<1500 cells/mm3
E32	Eq-Comparison:T66 Operator:T32 Value:T54 Unit:T147 Per:T41
T67	Or 30 32	or
E2	Or:T67 Arg:T6 Arg2:T5
T68	And 102 106	with
E4	And:T68 Arg:E1 Arg2:E3
T69	Condition 166 168	GO
E5	Condition:T69 Name:T70 Severity:T73 Temporality:E8
T70	Condition-Name 166 168	GO
T72	Severity 147 155	moderate
A19	Severity-Value T72 moderate
T73	Severity 159 165	severe
A20	Severity-Value T73 severe
T71	Or 156 158	to
E6	Or:T71 Arg:T72 Arg2:T73
T74	Eq-Comparison 139 145	active
E8	Eq-Comparison:T74 Temporal-Period:T75
T75	Eq-Temporal-Period 139 145	active
A21	Eq-Temporal-Period-Value T75 present
R1	Caused-By Arg1:E3 Arg2:E5	
T76	Observation 176 199	Clinical Activity Score
E10	Observation:T76 Name:T77
T77	Observation-Name 176 199	Clinical Activity Score
A22	Observation-Type-Value T77 clinical-score
R2	Abbrev-Of Arg1:E7 Arg2:E10	
T78	Study 248 257	Screening
E12	Study:T78 
T80	Severity 223 231	severely
A23	Severity-Value T80 severe
T45	Modifier 232 244	affected eye
E14	Modifier:T45 Modifies:T8
T79	Temporal-Connection 245 247	at
E16	Temporal-Connection:T79 Arg:E7 Arg2:E12
A24	Temporal-Connection-Type-Value E16 during
T81	Study 284 292	Baseline
E18	Study:T81 
T82	And 280 283	and
E20	And:T82 Arg:E12 Arg2:E18
T46	Eq-Comparison 322 327	Onset
E33	Eq-Comparison:T46 Temporal-Recency:T83
T83	Eq-Temporal-Recency 322 327	Onset
A25	Eq-Temporal-Recency-Value T83 first-time
T84	Eq-Comparison 331 337	active
E34	Eq-Comparison:T84 Temporal-Period:T85
T85	Eq-Temporal-Period 331 337	active
A26	Eq-Temporal-Period-Value T85 present
T86	Condition 338 340	GO
E35	Condition:T86 Name:T87 Temporality:E34 Temporality2:E33 Temporality3:E25
T87	Condition-Name 338 340	GO
T88	Study 360 369	screening
E36	Study:T88 
T89	Temporal-Connection 357 359	of
E37	Temporal-Connection:T89 Arg:E25 Arg2:E36
A27	Temporal-Connection-Type-Value E37 before
T90	Condition 402 404	GO
E38	Condition:T90 Name:T91 Severity:T94 Temporality:E39
T91	Condition-Name 402 404	GO
T92	Eq-Comparison 395 401	active
E39	Eq-Comparison:T92 Temporal-Period:T93
T93	Eq-Temporal-Period 395 401	active
A28	Eq-Temporal-Period-Value T93 present
T94	Severity 388 394	severe
A29	Severity-Value T94 severe
T95	Severity 376 384	Moderate
A30	Severity-Value T95 severe
T96	Or 385 387	to
E40	Or:T96 Arg:T95 Arg2:T94
T11	Condition 410 427	sight-threatening
E11	Condition:T11 Name:T12
T12	Condition-Name 410 427	sight-threatening
T97	Negation 406 409	not
E41	Negation:T97 Negates:E11
R4	Caused-By Arg1:E11 Arg2:E38	
T98	Observation 461 471	daily life
E42	Observation:T98 Name:T99 Stability:T100
T99	Observation-Name 461 471	daily life
T100	Stability 451 457	impact
A31	Stability-Value T100 change
T101	And 428 431	but
E43	And:T101 Arg:E41 Arg2:E42
R3	Caused-By Arg1:T100 Arg2:E38	
T102	Criteria-Count 513 526	the following
E44	Criteria-Count:T102 Min-Value:E88 Criteria:E45 Criteria2:E46 Criteria3:E9 Criteria4:E48
T103	Observation 528 542	lid retraction
E45	Observation:T103 Name:T104 Eq-Comparison:E26
T104	Observation-Name 528 542	lid retraction
A32	Observation-Type-Value T104 measurement
T105	Condition 570 593	soft tissue involvement
E46	Condition:T105 Name:T106 Severity:T107
T106	Condition-Name 570 593	soft tissue involvement
T107	Severity 563 569	severe
A33	Severity-Value T107 severe
T108	Severity 551 559	moderate
A34	Severity-Value T108 moderate
T109	Or 560 562	or
E47	Or:T109 Arg:T108 Arg2:T107
T110	Eq-Unit 618 624	normal
A35	Eq-Unit-Value T110 ref-range-normal
T111	Condition 676 684	diplopia
E48	Condition:T111 Name:T112
T112	Condition-Name 676 684	diplopia
T113	Modifier 667 675	constant
E49	Modifier:T113 Modifies:T112
T114	Modifier 653 663	inconstant
E50	Modifier:T114 Modifies:T112
T115	Or 664 666	or
E51	Or:T115 Arg:E50 Arg2:E49
T116	Or 646 652	and/or
E52	Or:T116 Arg:E9 Arg2:E48
T117	Drug 795 802	steroid
E53	Drug:T117 Name:T118 Dose:E28 Temporality:E29
T118	Drug-Name 795 802	steroid
T119	Modifier 804 815	intravenous
E54	Modifier:T119 Modifies:E53
T120	Modifier 817 819	IV
E55	Modifier:T120 
R9	Abbrev-Of Arg1:E55 Arg2:E54	
T121	Modifier 824 828	oral
E56	Modifier:T121 Modifies:E53
T122	Or 821 823	or
E57	Or:T122 Arg:E55 Arg2:E56
T123	Eq-Unit 871 872	g
T124	Drug 876 894	methylprednisolone
E58	Drug:T124 Name:T125
T125	Drug-Name 876 894	methylprednisolone
T126	Condition 916 918	GO
E59	Condition:T126 Name:T127
T127	Condition-Name 916 918	GO
R10	Example-Of Arg1:E58 Arg2:E53	
R11	Treatment-For Arg1:E53 Arg2:E59	
T128	Study 943 952	Screening
E60	Study:T128 
T129	Temporal-Connection 934 939	prior
E61	Temporal-Connection:T129 Arg:E29 Arg2:E60
A36	Temporal-Connection-Type-Value E61 before
T130	Drug 966 975	rituximab
E62	Drug:T130 Name:T131 Temporality:E30
T131	Drug-Name 966 975	rituximab
T132	Drug 977 988	tocilizumab
E63	Drug:T132 Name:T133 Temporality:E30
T133	Drug-Name 977 988	tocilizumab
T134	Drug 997 1016	monoclonal antibody
E64	Drug:T134 Name:T135 Temporality:E30
T135	Drug-Name 997 1016	monoclonal antibody
T136	Or 990 992	or
E65	Or:T136 Arg:E63 Arg2:E64
R12	Treatment-For Arg1:E64 Arg2:E13	
T137	Study 1072 1080	Baseline
E66	Study:T137 
T138	Temporal-Connection 1063 1068	prior
E67	Temporal-Connection:T138 Arg:E30 Arg2:E66
A37	Temporal-Connection-Type-Value E67 before
T139	Observation 1087 1102	Total IgG level
E68	Observation:T139 Name:T140 Eq-Comparison:E31
T140	Observation-Name 1087 1102	Total IgG level
A38	Observation-Type-Value T140 lab
T141	Eq-Unit 1106 1107	g
T142	Eq-Unit 1108 1109	L
T143	Study 1113 1122	Screening
E69	Study:T143 
T144	Temporal-Connection 1110 1112	at
E70	Temporal-Connection:T144 Arg:E68 Arg2:E69
A39	Temporal-Connection-Type-Value E70 during
T145	Observation 1129 1154	Absolute neutrophil count
E71	Observation:T145 Name:T146 Eq-Comparison:E32
T146	Observation-Name 1129 1154	Absolute neutrophil count
A40	Observation-Type-Value T146 lab
T147	Eq-Unit 1161 1166	cells
T148	Study 1174 1183	Screening
E72	Study:T148 
T149	Temporal-Connection 1171 1173	at
E73	Temporal-Connection:T149 Arg:E71 Arg2:E72
A41	Temporal-Connection-Type-Value E73 during
T150	Condition 1218 1246	best corrected visual acuity
E74	Condition:T150 Name:T151 Polarity:T152
T151	Condition-Name 1218 1246	best corrected visual acuity
T152	Polarity 1208 1217	decreased
A42	Polarity-Value T152 low
R13	Caused-By Arg1:E74 Arg2:E15	
T19	Eq-Comparison 1309 1316	2 lines
E19	Eq-Comparison:T19 Value:T20 Unit:T55
T20	Eq-Value 1309 1310	2
T55	Eq-Unit 1311 1316	lines
T153	Observation 1287 1305	decrease in vision
E75	Observation:T153 Name:T154 Eq-Comparison:E19
T154	Observation-Name 1287 1305	decrease in vision
A43	Observation-Type-Value T154 measurement
R14	Equivalent-To Arg1:E75 Arg2:E15	
T155	Condition 1343 1362	visual field defect
E76	Condition:T155 Name:T156 Temporality:E77
T156	Condition-Name 1343 1362	visual field defect
T157	Eq-Comparison 1339 1342	new
E77	Eq-Comparison:T157 Temporal-Recency:T158
T158	Eq-Temporal-Recency 1339 1342	new
A44	Eq-Temporal-Recency-Value T158 first-time
T159	Condition 1367 1379	color defect
E78	Condition:T159 Name:T160 Temporality:E77
T160	Condition-Name 1367 1379	color defect
T161	Or 1364 1366	or
E79	Or:T161 Arg:E76 Arg2:E78
R15	Equivalent-To Arg1:E76 Arg2:E15	
R16	Caused-By Arg1:E78 Arg2:E17	
T162	Modifier 1405 1416	involvement
E80	Modifier:T162 Modifies:T18
R17	Equivalent-To Arg1:E17 Arg2:E15	
T163	Eq-Comparison 1417 1441	within the last 6 months
E81	Eq-Comparison:T163 Operator:T33 Temporal-Period:T164 Value:T56 Temporal-Unit:T38
T164	Eq-Temporal-Period 1428 1432	last
A45	Eq-Temporal-Period-Value T164 past
T165	Study 1445 1454	Screening
E82	Study:T165 
T166	Temporal-Connection 1442 1444	at
E83	Temporal-Connection:T166 Arg:E17 Arg2:E82
A46	Temporal-Connection-Type-Value E83 during
T167	Eq-Comparison 1461 1469	Previous
E84	Eq-Comparison:T167 Temporal-Period:T168
T168	Eq-Temporal-Period 1461 1469	Previous
A47	Eq-Temporal-Period-Value T168 past
T169	Condition 1505 1507	GO
E85	Condition:T169 Name:T170
T170	Condition-Name 1505 1507	GO
T171	Procedure 1493 1500	surgery
E86	Procedure:T171 Name:T172 Temporality:E84
T172	Procedure-Name 1493 1500	surgery
T173	Or 1490 1492	or
E87	Or:T173 Arg:E21 Arg2:E86
R18	Treatment-For Arg1:E86 Arg2:E85	
T174	Eq-Comparison 498 509	one or more
E88	Eq-Comparison:T174 Value:T175 Operator:T176
T175	Eq-Value 498 501	one
T176	Eq-Operator 502 509	or more
A48	Eq-Operator-Value T176 GTEQ
R5	Equivalent-To Arg1:E44 Arg2:E38	
T177	Eq-Operator 612 617	above
A49	Eq-Operator-Value T177 GT
R6	Treatment-For Arg1:E63 Arg2:E13	
R7	Treatment-For Arg1:E62 Arg2:E13	
T178	Modifier 1324 1337	Snellen chart
E89	Modifier:T178 Modifies:E75
R8	Treatment-For Arg1:E21 Arg2:E85	
